Fig. 3From: Head-to-head comparison of 18F-FAPI and 18F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinomaA 41-year-old male patient (Patient No. 51) with HCC (moderately differentiated) was confirmed by biopsy. 18F-FDG PET/CT displayed moderate uptake in the section II of the liver; However, the corresponding CT scan showed more nodules in other lobes of the liver. 18F-FAPI PET/CT detects greater radiotracer in primary lesions and other intrahepatic subfoci on both MIP (large arrow) and axial images (small arrow)Back to article page